AxoGen, Inc. (AXGN) Balance Sheet

NASDAQ: AXGNAssets, liabilities, debt and equity over 10 years.

AXGN balance sheet, 2025

December 31, 2025 · U.S. dollars

$221.7M assets = $92.8M liabilities + $128.8M equity

What it owns$221.7MCash & ST investments: $35.5M (16.0%)Cash & ST investments$35.5M · 16%Receivables: $26.2M (11.8%)Receivables$26.2M · 12%Inventory: $42.4M (19.1%)Inventory$42.4M · 19%Other current: $16.3M (7.4%)Other current $16.3MPP&E: $94.5M (42.6%)PP&E$94.5M · 43%Goodwill & intangibles: $6.8M (3.0%)=How it is financed$221.7MCurrent liabilities: $23.6M (10.6%)Current liabilities $23.6MLong-term debt: $48.4M (21.8%)Long-term debt$48.4M · 22%Other LT liabilities: $20.9M (9.4%)$20.9MShareholders’ equity: $128.8M (58.1%)Shareholders’ equity$128.8M · 58%

Both columns are drawn to the same scale: what AXGN owns equals what it owes plus shareholders’ equity. Hover a block for its value.

AXGN financial health

Current ratio5.11
Comfortable · current assets cover current liabilities 5.11×
Debt / equity0.52
Moderate leverage · $0.52 of debt for each $1 of equity
Equity / assets58.1%
Equity-funded · of assets funded by shareholders
Cash / debt52.6%
Partial cover · cash & short-term investments vs total debt
Goodwill & intangibles3.0%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

AXGN balance sheet trends, 2016–2025

AxoGen, Inc. balance sheet trends
MetricTrendThenLatestChange
Total assets$46.4M2016$221.7M2025+19.0%/yr
Total liabilities$31.4M2016$92.8M2025+12.8%/yr
Shareholders’ equity$14.9M2016$128.8M2025+27.1%/yr
Cash & short-term investments$30.0M2016$35.5M2025+1.9%/yr
Total debt$24.3M2016$67.6M2025+12.0%/yr
Net cash (debt)$5.7M2016−$32.1M2025−$37.8M
Working capital$33.0M2016$96.9M2025+$63.9M
Book value per share$0.492016$2.802025+21.5%/yr
Current ratio3.9720165.112025+1.14
Debt / equity1.6320160.522025−1.10
Shares outstanding30.7M201646.1M2025+4.6%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

AXGN assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

AXGN liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

AXGN debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

AXGN balance sheet

AxoGen, Inc. annual balance sheet
2025202420232022202120202019201820172016
Assets
Cash & short-term investments$35.5M$33.5M$31.0M$48.8M$84.1M$104.0M$96.5M$116.6M$36.5M$30.0M
Cash & equivalents$35.5M$27.6M$31.0M$15.3M$32.8M$48.8M$35.7M$24.3M$36.5M$30.0M
Short-term investments$6.0M$5.9M−$6.0M$33.5M$51.3M$55.2M$60.8M$92.3M$0$0
Receivables$26.2M$24.1M$25.1M$22.2M$18.2M$17.6M$16.9M$15.3M$11.1M$8.1M
Inventory$42.4M$33.2M$23.0M$18.9M$16.7M$12.5M$13.9M$12.0M$7.3M$5.5M
Other current assets$16.3M$8.4M$8.8M$8.2M$8.1M$11.1M$7.7M$7.0M$853,381$511,804
Total current assets$120.4M$99.2M$88.0M$98.1M$127.0M$145.3M$135.0M$151.0M$55.7M$44.0M
Property, plant & equipment (net)$94.5M$98.9M$104.3M$93.7M$78.1M$54.1M$18.1M$8.0M$2.2M$1.5M
Goodwill & intangible assets$6.8M$5.6M$4.5M$3.6M$2.9M$2.1M$1.5M$1.2M$936,992$828,979
Long-term investments$0$0$0$0$0$0$0$0$0$0
Other non-current assets$0$0$0$0$0$0$0$0$0$0
Total assets$221.7M$203.7M$196.8M$195.4M$208.0M$201.4M$154.6M$160.2M$58.9M$46.4M
Liabilities
Accounts payable$2.9M$8.0M$11.8M$9.0M$5.9M$4.6M$8.3M$4.5M$3.2M$3.6M
Short-term debt$2.4M$2.0M$1.5M$1.3M$1.8M$863,000$1.7M$28,000$6.9M$4.0M
Deferred revenue——————$14,000$18,000$31,668$33,282
Total current liabilities$23.6M$30.6M$30.4M$23.8M$24.3M$22.8M$20.9M$13.0M$13.7M$11.1M
Long-term debt$48.4M$47.5M$46.6M$66.1M$65.6M$52.9M$30,000$35,000$19.9M$20.3M
Lease obligations$19.2M$21.2M$22.7M$21.7M$22.6M$20.9M————
Other long-term liabilities$20.9M$21.7M$24.1M$4.5M$5.6M$2.5M$1.6M$112,000$68,631$92,215
Total liabilities$92.8M$99.8M$101.2M$94.4M$95.5M$78.2M$22.5M$13.2M$33.7M$31.4M
Shareholders' equity
Common stock & paid-in capital$472,000$441,000$431,000$424,000$417,000$406,000$396,000$389,000$343,503$330,088
Retained earnings (deficit)−$307.0M−$291.3M−$281.3M−$259.6M−$230.6M−$203.6M−$179.9M−$150.7M−$128.3M−$117.9M
Treasury stock————————$0$0
Accumulated other comprehensive income——$0———−$3.8M−$2.9M−$2.3M−$1.8M
Minority interest————————$0$0
Total shareholders' equity$128.8M$103.9M$95.7M$101.0M$112.5M$123.1M$132.2M$147.0M$25.2M$14.9M
Key figures
Total debt$67.6M$68.7M$69.3M$67.4M$67.5M$53.8M$4.9M$63,000$24.6M$24.3M
Net cash (debt)−$32.1M−$35.2M−$38.3M−$18.6M$16.6M$50.2M$91.6M$116.5M$11.9M$5.7M
Working capital$96.9M$68.6M$57.6M$74.3M$102.8M$122.4M$114.1M$137.9M$42.0M$33.0M
Tangible book value$122.1M$98.3M$91.1M$97.3M$109.7M$121.1M$130.6M$145.8M$24.2M$14.1M
Book value per share$2.80$2.35$2.23$2.40$2.73$3.08$3.37$3.96$0.76$0.49
Shares outstanding46.1M44.3M42.9M42.1M41.2M40.0M39.2M37.1M33.3M30.7M
Current ratio5.113.242.894.135.236.366.4711.574.063.97
Quick ratio2.621.881.852.994.215.335.4310.113.473.44
Debt / equity0.520.660.720.670.600.440.040.000.981.63
Equity / assets58.1%51.0%48.6%51.7%54.1%61.2%85.5%91.8%42.8%32.2%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed February 24, 2026); data from EODHD.

AXGN financial position

At the end of fiscal 2025 (December 31, 2025), AxoGen had total assets of $221.7 million (up 8.8% from a year earlier), total liabilities of $92.8 million and shareholders' equity of $128.8 million. It held $35.5 million in cash and short-term investments against $67.6 million of debt, net debt of $32.1 million. Its current ratio was 5.11. In the latest quarter (ended June 30, 2026) total assets were $304.9 million and equity $256.3 million.

Related: AXGN income statement, AXGN cash flow statement, AXGN key metrics. See the AXGN stock overview for the latest quote and news.

AXGN balance sheet FAQ

What are AxoGen's total assets?

AxoGen reported total assets of $221.7 million at the end of fiscal 2025 (December 31, 2025), compared with $203.7 million a year earlier.

How much debt does AxoGen have?

AxoGen had $67.6 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.52.

How much cash does AxoGen have?

AxoGen held $35.5 million in cash and short-term investments at the end of fiscal 2025; with $67.6 million of debt that is net debt of $32.1 million.

What is AxoGen's book value?

AxoGen's shareholders' equity (book value) was $128.8 million at the end of fiscal 2025, or $2.80 per share.

What is AxoGen's current ratio?

AxoGen had current assets of $120.4 million and current liabilities of $23.6 million, a current ratio of 5.11 (it can cover its short-term obligations).

How much goodwill does AxoGen have?

AxoGen carried $6.8 million of goodwill and intangible assets, 3.0% of total assets, at the end of fiscal 2025.

Medical Devices: balance sheet